CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 80 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-31 | LAFRANCE JAMES T Director | Grant or award | +72,937 | 496,129 | ||
| 2022-03-31 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right to Buy) | +110,305 | 110,305 | ||
| 2021-06-24 | LAFRANCE JAMES T Director | Grant or award | +330 | 423,192 | ||
| 2021-06-24 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right To Buy) | +502 | 502 | ||
| 2021-05-06 | LAFRANCE JAMES T Director | Grant or award | +423 | 422,862 | ||
| 2021-05-06 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right To Buy) | +720 | 720 | ||
| 2021-03-19 | LAFRANCE JAMES T Director | Grant or award | +9,205 | 422,439 | ||
| 2021-03-19 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right to Buy) | +15,412 | 15,412 | ||
| 2020-06-02 | LAFRANCE JAMES T Director | Option exercise | +5,021 | $1.80 | $9K | 434,480 |
| 2020-06-02 | LAFRANCE JAMES T Director | Option exercise · Warrants to acquire Common Stock | −5,021 | 0 | ||
| 2020-06-02 | LAFRANCE JAMES T Director | Option exercise | +5,210 | $1.80 | $9K | 434,480 |
| 2020-06-02 | LAFRANCE JAMES T Director | Option exercise · Warrants to acquire stock | −5,210 | $0.13 | $651 | 0 |
| 2020-03-19 | LAFRANCE JAMES T Director | Grant or award | +84,986 | 429,459 | ||
| 2020-03-19 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right to Buy) | +147,783 | 147,783 | ||
| 2019-03-26 | LAFRANCE JAMES T Director | Grant or award | +45,455 | 344,473 | ||
| 2019-03-26 | LAFRANCE JAMES T Director | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +119,284 | 119,284 | ||
| 2019-03-26 | LAFRANCE JAMES T Director | Grant or award | +45,455 | 343,473 | ||
| 2019-03-26 | LAFRANCE JAMES T Director | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +119,284 | 119,284 | ||
| 2018-08-20 | LAFRANCE JAMES T Director | Sale | −2,900 | $0.54 | $2K | 298,018 |
| 2018-08-17 | LAFRANCE JAMES T Director | Sale | −7,500 | $0.51 | $4K | 300,918 |
Page 1 of 2 · 38 trades